Australian Statistics on Medicines 2010

Table 1 - General Antiinfectives For Systemic Use

J01 - ANTIBACTERIALS FOR SYSTEMIC USE

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
TETRACYCLINES
TETRACYCLINES
J01AA02 DOXYCYCLINE
P 2702F Tablet 100mg (HCl salt after 1 Oct 2007) 28 0.10 GM 62,868 908,276
P 2703G Capsule 100mg (as HCl salt after 1 Oct 2007) 0.10 GM 49,413 715,878
P 2707L Capsule 50mg (as HCl salt after 1 Oct 2007) 0.10 GM 271,106 2,763,037
P 2708M Capsule 100mg (as HCl salt after 1 Oct 2007) 0.10 GM 278,195 2,434,591
P 2709N Tablet 100mg (as HCl salt after 1 Oct 2007) 0.10 GM 290,338 2,578,835
P 2711Q Tablet 50mg (as HCl salt after 1 Oct 2007) 25 0.10 GM 256,718 2,634,067
P 2714W Tablet 100mg (as HCl salt after 1 Oct 2007) 21 0.10 GM 43,711 540,044
P 2715X Capsule 100mg (as HCl salt after 1 Oct 2007) 0.10 GM 33,647 419,222
P 3321T Tablet 100mg 0.10 GM 3,759 31,837
P 3322W Capsule 100mg 0.10 GM 748 6,339
P 5082L Tablet 100mg (monohydrate) 7 0.10 GM 519 4,394
P 9105F Tablet 100mg (monohydrate) 7 0.10 GM 130,739 1,107,611
P 9106G Tablet 50mg (as monohydrate) 25 0.10 GM 193,106 1,948,199
P 9107H Tablet 100mg (monohydrate) 28 0.10 GM 26,742 385,398
P 9108J Tablet 100mg (as monohydrate) 21 0.10 GM 14,437 178,090
J01AA08 MINOCYCLINE
P 1616C Tablet 50mg 0.20 GM 392,429 6,055,631
P 3037W Capsule 100mg 0.20 GM 3,020 29,417
BETA-LACTAM ANTIBACTERIALS,PENICILLINS
PENICILLINS WITH EXTENDED SPECTRUM
J01CA04 AMOXYCILLIN
P 1878W Sachet containing oral powder 3g 1.00 GM 14,037 137,436
P 1884E Capsule 250mg 1.00 GM 348,523 3,006,792
P 1886G Powder for syrup 125mg per 5mL 100mL 1.00 GM 625,989 6,790,416
P 1887H Powder for syrup 250mg per 5mL 100mL 1.00 GM 1,080,743 12,672,851
P 1888J Powder paediatric oral drops 100mg per mL 20mL 1.00 GM 214,157 2,825,269
P 1889K Capsule 500mg 1.00 GM 3,161,388 34,074,751
P 3300Q Capsule 500mg 1.00 GM 546,426 5,785,536
P 3301R Capsule 250mg 1.00 GM 48,429 413,895
P 3302T Powder for syrup 125mg per 5mL 100mL 1.00 GM 11,231 121,770
P 3309E Sachet containing oral powder 3g 1.00 GM 26,051 237,331
P 3393N Powder for syrup 250mg per 5mL 100mL 1.00 GM 16,521 193,098
P 5225B Powder for oral suspension 500mg per 5mL 100mL 1.00 GM 254 3,738
P 8581P Tablet 1g 14 1.00 GM 186,253 2,021,743
P 8705E Powder for oral suspension 500mg per 5mL 100mL 1.00 GM 47,745 705,961
P 9714G Powder paediatric oral drops 100mg per mL 20mL 1.00 GM 157 306
J01CA01 AMPICILLIN
P 2977Q Injection 1g (solvent required) 2.00 GM 6,984 118,724
BETA-LACTAMASE SENSITIVE PENICILLINS
J01CE08 BENZATHINE PENICILLIN
P 2267H Injection 900mg in 2.3mL cartridge-needle unit 3.60 GM 1,441 374,846

J01 - ANTIBACTERIALS FOR SYSTEMIC USE

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
BETA-LACTAM ANTIBACTERIALS,PENICILLINS
J01CE10 BENZATHINE PHENOXYMETHYLPENICILLIN
P 5012T Oral suspension 150mg per 5mL 100mL 2.00 GM 223 4,016
P 9143F Oral suspension 150mg per 5mL 100mL 2.00 GM 162,229 3,549,102
J01CE01 BENZYLPENICILLIN
P 1775K Injection 600mg (solvent required) 3.60 GM 5,770 515,647
P 2647H Injection 3g (solvent required) 3.60 GM 1,730 180,901
P 3486L Injection 600mg (with sterilised water) 3.60 GM 2,259 85,502
P 3487M Injection 3g (solvent supplied) 3.60 GM 1,738 22,161
J01CE02 PHENOXYMETHYLPENICILLIN
P 1703P Tablet 250mg 2.00 GM 10,047 116,453
P 1705R Capsule 250mg 2.00 GM 30,129 343,883
P 1787C Tablet 250mg 2.00 GM 23,405 263,655
P 1789E Capsule 250mg 2.00 GM 27,308 309,026
P 2965C Capsule 500mg 2.00 GM 261,236 3,627,854
P 3028J Tablet 500mg 2.00 GM 114,288 1,570,076
P 3360W Tablet 250mg 2.00 GM 1,768 16,345
P 3361X Tablet 500mg 2.00 GM 3,334 35,427
P 3363B Capsule 250mg 2.00 GM 1,508 15,451
P 3364C Capsule 500mg 2.00 GM 7,322 85,955
J01CE09 PROCAINE PENICILLIN
P 1794K Injection 1.5g 0.60 GM 6,811 628,423
P 3485K Injection 1.5g 3.60 GM 18,428 1,698,539
BETA-LACTAMASE RESISTANT PENICILLINS
J01CF01 DICLOXACILLIN
P 8121K Capsule 250mg 2.00 GM 27,298 320,220
P 8122L Capsule 500mg 2.00 GM 308,813 5,966,086
J01CF05 FLUCLOXACILLIN
P 1524F Injection 500mg (solvent required) 2.00 GM 168 2,945
P 1525G Injection 1g (solvent required) 2.00 GM 14,239 747,825
P 1526H Capsule 250mg 2.00 GM 60,503 717,302
P 1527J Capsule 500mg 2.00 GM 403,651 7,760,583
A 20436 Powder for syrup 250mg per 5mL 100mL 2.00 GM 246 —
P 5091Y Capsule 500mg 2.00 GM 251 4,221
P 9149M Powder for oral liquid 125mg per 5mL 100mL 2.00 GM 20,171 336,533
P 9150N Powder for oral liquid 250mg per 5mL 100mL 2.00 GM 52,808 1,213,068
COMBINATIONS OF PENICILLINS, INCL.BETA-LACTAMASE INHIBITORS
J01CR02 AMOXYCILLIN with CLAVULANIC ACID
P 1891M Tablet 500mg-125mg 1.00 GM 460,268 5,696,561
P 1892N Powder for syrup 125mg-31.25mg per 5mL 75mL 1.00 GM 70,821 890,601
P 5006L Tablet 875mg-125mg 1.00 GM 55,496 808,911
P 5008N Tablet 500mg-125mg 1.00 GM 13,057 158,768
P 5011R Powder for syrup 400mg-57mg per 5mL 50mL 1.00 GM 265 3,700
P 8254K Tablet 875mg-125mg 1.00 GM 2,998,928 44,786,759

J01 - ANTIBACTERIALS FOR SYSTEMIC USE

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
BETA-LACTAM ANTIBACTERIALS,PENICILLINS
P 8319W Powder for syrup 400mg-57mg per 5mL 50mL 1.00 GM 474,874 6,967,080
J01CR03 TICARCILLIN with CLAVULANIC ACID
P 2179Q Injection 3g-100mg (solvent required) 15.00 GM 26,876 4,531,387
P 6884H Injection 3g-100mg 10mL and NS 15.00 GM 6,358 1,307,556
OTHER BETA-LACTAM ANTIBACTERIALS
FIRST-GENERATION CEPHALOSPORINS
J01DB01 CEFALEXIN
P 3058Y Capsule 250mg 2.00 GM 328,468 2,978,469
P 3094W Granules for syrup 125mg per 5mL 100mL 2.00 GM 154,939 1,838,661
P 3095X Granules for syrup 250mg per 5mL 100mL 2.00 GM 452,311 6,155,727
P 3119E Capsule 500mg 2.00 GM 3,887,208 42,513,364
P 3317N Capsule 250mg 2.00 GM 3,126 27,657
P 3318P Capsule 500mg 2.00 GM 30,173 324,147
P 3320R Granules for syrup 250mg per 5mL 100mL 2.00 GM 1,117 14,802
J01DB03 CEFALOTHIN
P 2964B Injection 1g (solvent required) 4.00 GM 32,373 1,127,035
J01DB04 CEPHAZOLIN
P 1257E Injection 1g (solvent required) 3.00 GM 30,534 1,904,261
P 9326W Powder for injection 2g 10 3.00 GM 525 99,774
SECOND-GENERATION CEPHALOSPORINS
J01DC04 CEFACLOR
P 1169M Tablet 375mg (sustained release) 1.00 GM 584,382 7,632,949
P 2460L Powder for oral susp 125mg per 5mL 100mL 1.00 GM 118,005 1,592,874
P 2461M Powder for oral susp 250mg per 5mL 75mL 1.00 GM 279,132 3,879,351
P 5045M Tablet 375mg (sustained release) 1.00 GM 2,384 30,748
P 5047P Powder for oral susp 250mg per 5mL 75mL 1.00 GM 226 3,130
J01DC02 CEFUROXIME
P 8292K Tablet 250mg 14 0.50 GM 111,342 2,170,969
THIRD-GENERATION CEPHALOSPORINS
J01DD01 CEFOTAXIME
P 1085D Injection 1g (solvent required) 4.00 GM 1,327 33,373
P 1086E Injection 2g (solvent required) 4.00 GM 316 13,758
J01DD04 CEFTRIAXONE
P 1784X Injection 1g (solvent required) 2.00 GM 50,550 1,855,294
P 1785Y Injection 2g (solvent required) 2.00 GM 6,087 395,406
A 18777 Injection 1g (solvent required) 2.00 GM 118 —
P 9058R Injection 500mg (solvent required) 2.00 GM 2,009 20,848
FOUTH-GENERATION CEPHALOSPORINS
J01DE01 CEFEPIME
P 8315P Injection 1g (solvent required) 2.00 GM 431 99,516
P 8316Q Injection 2g (solvent required) 2.00 GM 327 156,854
SULFONAMIDES AND TRIMETHOPRIM
TRIMETHOPRIM AND DERIVATIVES

J01 - ANTIBACTERIALS FOR SYSTEMIC USE

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
SULFONAMIDES AND TRIMETHOPRIM
J01EA01 TRIMETHOPRIM
P 2922T Tablet 300mg 0.40 GM 803,856 6,951,346
COMBINATIONS OF SULFONAMIDES AND TRIMETHOPRIM, INCL. DERIVATIVES
J01EE01 TRIMETHOPRIM with SULPHAMETHOXAZOLE
P 2949F Tablet 80mg-400mg — — 5,368 56,547
P 2951H Tablet 160mg-800mg — — 336,516 3,496,145
P 3103H Oral suspension 40mg-200mg per 5mL 100mL — — 109,789 1,018,575
P 3390K Tablet 160mg-800mg — — 1,120 10,499
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
MACROLIDES
J01FA10 AZITHROMYCIN
A 19032 Tablet 500mg 3 0.30 GM 113,272 —
A 20776 Tablet 500mg 3 0.30 GM 3,126 —
P 4115N Tablet 500mg 0.30 GM 6,342 307,965
P 6221K Tablet 600mg 16 0.30 GM 130 7,042
P 8200N Tablet 500mg 0.30 GM 59,752 1,298,229
P 8201P Powder for oral suspension 200mg per 5mL 15mL 0.30 GM 7,228 155,282
P 8336R Tablet 500mg 2 0.30 GM 53,535 1,146,601
J01FA09 CLARITHROMYCIN
P 6151R Tablet 250mg 100 0.50 GM 155 5,995
P 6152T Tablet 500mg 100 0.50 GM 318 24,547
P 8318T Tablet 250mg 14 0.50 GM 920,843 12,001,794
P 9192T Powder for oral liquid 250mg per 5mL 50mL 0.50 GM 30,058 1,151,995
J01FA01 ERYTHROMYCIN
P 1397M I.V. infusion 1g (base) 1.00 GM 678 59,936
P 1404X Capsule 250mg 1.00 GM 152,492 1,500,061
P 2424N Granules for paediatric oral susp 200mg 1.00 GM 181,728 2,246,220
P 2428T Granules for oral susp 400mg (base) per 5mL 10 1.00 GM 211,331 2,855,863
P 2750R Tablet 400mg (base) 1.00 GM 479,804 5,388,028
P 3325B Capsule 250mg 1.00 GM 14,965 140,848
P 3334L Granules for paediatric oral suspension 200mg 1.00 GM 215 2,644
P 3336N Tablet 400mg (base) 1.00 GM 7,321 79,620
J01FA06 ROXITHROMYCIN
P 1760P Tablet 150mg 10 0.30 GM 930,040 11,110,824
P 5260W Tablet 150mg 10 0.30 GM 461 5,416
P 5261X Tablet 300mg 5 0.30 GM 532 6,255
P 8016X Tablet 300mg 5 0.30 GM 1,317,252 15,879,330
P 8129W Tablet for oral suspension 50mg 10 0.30 GM 83,614 1,123,552
LINCOSAMIDES
J01FF01 CLINDAMYCIN
P 3138E Capsule 150mg 1.20 GM 147,925 5,187,012
P 5057E Capsule 150mg 1.20 GM 40,968 800,021
J01FF02 LINCOMYCIN

J01 - ANTIBACTERIALS FOR SYSTEMIC USE

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
P 2530E Injection 600mg in 2mL 1.80 GM 3,622 134,768
AMINOGLYCOSIDE ANTIBACTERIALS
OTHER AMINOGLYCOSIDES
J01GB03 GENTAMICIN SULPHATE
P 2824P Injection 80mg (base) in 2mL 0.24 GM 18,843 393,873
J01GB01 TOBRAMYCIN
P 1356J Injection 80mg (base) 0.24 GM 2,556 297,252
P 8872Y Injection 80mg (base) in 2mL (without preserv) 0.24 GM 1,313 158,992
QUINOLONE ANTIBACTERIALS
FLUOROQUINOLONES
J01MA02 CIPROFLOXACIN
P 1208N Tablet 250mg 1.00 GM 18,228 733,422
P 1209P Tablet 500mg 1.00 GM 143,917 9,556,428
P 1210Q Tablet 750mg 1.00 GM 40,256 4,312,012
P 1311B Tablet 250mg 1.00 GM 824 10,068
A 21046 Tablet 250mg 2 1.00 GM 749 —
J01MA14 MOXIFLOXACIN
A 20350 Tablet 400mg 5 0.40 GM 4,371 —
J01MA06 NORFLOXACIN
A 13660 Tablet 400mg 6 0.80 GM 49,340 —
P 3010K Tablet 400mg 0.80 GM 223,726 4,632,759
OTHER ANTIBACTERIALS
GLYCOPEPTIDE ANTIBACTERIALS
J01XA01 VANCOMYCIN
P 2269K Powder for injection 1gm (1000000iu) 1 2.00 GM 652 44,072
P 2270L Powder for injection 1gm (1000000iu) 3 2.00 GM 19,843 1,617,672
P 3130R Injection 500mg (500000iu) (solvent required) 2.00 GM 237 9,546
P 3131T Injection 500mg (500000iu) (solvent required) 2.00 GM 10,962 804,328
STEROID ANTIBACTERIALS
J01XC01 FUSIDIC ACID
P 2312Q Tablet (sodium salt) 250mg (enteric coated) 1.50 GM 20,498 3,953,262
IMIDAZOLE DERIVATIVES
J01XD01 METRONIDAZOLE
P 1638F I.V. infusion 500mg in 100mL 1.50 GM 14,468 448,041
NITROFURAN DERIVATIVES
J01XE01 NITROFURANTOIN
P 1692C Capsule 50mg 0.20 GM 65,773 1,345,482
P 1693D Capsule 100mg 0.20 GM 94,127 2,493,514
OTHER ANTIBACTERIALS
J01XX05 HEXAMINE HIPPURATE
P 3124K Tablet 1g 2.00 GM 87,666 3,709,051

J02 - ANTIMYCOTICS FOR SYSTEMIC USE

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIMYCOTICS FOR SYSTEMIC USE
ANTIMYCOTICS FOR SYSTEMIC USE
IMIDAZOLE DERIVATIVES
J02AB02 KETOCONAZOLE
P 1572R Tablet 200mg 0.20 GM 21,616 943,683
P 1573T Tablet 200mg 0.20 GM 28,926 621,642
TRIAZOLE DERIVATIVES
J02AC01 FLUCONAZOLE
A 14171 Capsule 150mg 1 0.20 GM 6,272 —
P 1471K Capsule 50mg 28 0.20 GM 5,187 465,382
P 1472L Capsule 100mg 28 0.20 GM 10,020 1,721,255
P 1474N Solution for IV infusion 200mg in 100mL 7 0.20 GM 653 325,021
P 1475P Capsule 200mg 0.20 GM 11,708 4,062,557
A 19776 Capsule 150mg 1 0.20 GM 863 —
A 19901 Capsule 150mg 1 0.20 GM 1,391 —
A 19919 Capsule 150mg 1 0.20 GM 366 —
A 20244 Capsule 150mg 1 0.20 GM 871 —
A 20517 Capsule 150mg 1 0.20 GM 636 —
A 20660 Capsule 150mg 1 0.20 GM 352 —
A 20799 Capsule 150mg 1 0.20 GM 1,692 —
J02AC02 ITRACONAZOLE
A 14810 Capsule 100mg 0.20 GM 2,133 —
A 16227 Capsule 100mg 28 0.20 GM 1,778 —
P 8196J Capsule 100mg 0.20 GM 6,874 2,203,793
J02AC04 POSACONAZOLE
P 9360P Oral suspension 40mg/mL 105, 1 0.80 GM 1,577 4,846,571
J02AC03 VORICONAZOLE
P 9363T Tablet 50mg 56 0.40 GM 603 731,571
P 9364W Tablet 200mg 56 0.40 GM 2,660 7,266,349

J04 - ANTIMYCOBACTERIALS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIMYCOBACTERIALS
DRUGS FOR TREATMENT OF TUBERCULOSIS
ANTIBIOTICS
J04AB04 RIFABUTIN
P 6195C Capsule 150mg 120 0.15 GM 198 7,817
J04AB02 RIFAMPICIN
P 1981G Capsule 150mg 0.60 GM 881 11,790
P 1982H Capsule 150mg 0.60 GM 590 19,877
P 1983J Capsule 300mg 0.60 GM 2,020 124,256
P 1984K Capsule 300mg 0.60 GM 7,258 115,817
P 8025J Syrup 100mg per 5mL 60mL 0.60 GM 441 19,194
HYDRAZIDES
J04AC01 ISONIAZID
P 1554T Tablet 100mg 0.30 GM 1,782 20,942
DRUGS FOR TREATMENT OF LEPRA
DRUGS FOR TREATMENT OF LEPRA
J04BA02 DAPSONE
P 1272Y Tablet 100mg 50.00 MG 3,138 348,317
P 8801F Tablet 25mg 50.00 MG 2,146 215,927

J05 - ANTIVIRALS FOR SYSTEMIC USE

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIVIRALS FOR SYSTEMIC USE
DIRECT ACTING ANTIVIRALS
NUCLEOSIDES AND NUCLEOTIDES EXCL. REVERSE TRANSCRIPTASE INHIBITORS
J05AB01 ACICLOVIR
P 1003T Tablet 200mg 4.00 GM 4,689 324,459
P 1007B Tablets 200mg 90 4.00 GM 29,426 3,640,036
P 1052J Tablets 800mg 35 4.00 GM 8,820 1,293,455
P 8234J Tablets 800mg 120 4.00 GM 151 65,072
J05AB09 FAMCICLOVIR
A 19696 Tablet 250mg 14 0.75 GM 236 —
A 19996 Tablet 500mg 3 0.75 GM 58,131 —
A 21238 Tablet 500mg 3 0.75 GM 4,474 —
A 21347 Tablet 500mg 3 0.75 GM 441 —
P 2274Q Tablet 250mg 20 0.75 GM 14,339 1,980,874
P 8002E Tablet 250mg 0.75 GM 55,661 7,930,903
P 8092X Tablet 125mg 0.75 GM 7,149 976,132
P 8217L Tablet 250mg 0.75 GM 78,862 28,203,214
P 8896F Tablet 500mg 56 0.75 GM 4,805 1,715,395
P 8897G Tablet 500mg 30 0.75 GM 2,815 564,992
J05AB11 VALACICLOVIR
A 20467 Tablet 1000mg 4 3.00 GM 6,467 —
P 8064K Tablet 500mg 42 3.00 GM 38,334 8,195,550
P 8133C Tablet 500mg 20 3.00 GM 18,264 1,935,118
P 8134D Tablet 500mg 30 3.00 GM 349,094 58,581,758
J05AB14 VALGANCICLOVIR
P 6357N Tablet 450mg (base) 120 0.90 GM 162 448,833
NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS
J05AF08 ADEFOVIR DIPIVOXIL
P 6450L Tablet 30mg 60 10.00 MG 4,111 3,212,507
J05AF02 DIDANOSINE
P 6300N Capsule 250mg (enteric coated beads) 60 0.40 GM 198 —
P 6301P Capsule 400mg (enteric coated beads) 60 0.40 GM 140 51,432
J05AF10 ENTECAVIR
P 9602J Tablet 0.5mg 60 0.50 MG 14,929 7,527,048
P 9603K Tablet 1mg 60 0.50 MG 3,039 2,374,600
J05AF05 LAMIVUDINE
P 6193Y Tablet 150mg 120 0.30 GM 344 48,846
P 6257H Tablet 100mg 56 0.30 GM 6,967 1,328,523
P 6435Q Tablet 300mg 60 0.30 GM 509 —
J05AF04 STAVUDINE
P 6190T Capsule 40mg 120 80.00 MG 195 —
J05AF07 TENOFOVIR
P 6358P Tablet containing tenofovir disoproxil fumarate 300mg 60 0.25 GM 8,098 5,112,416
J05AF01 ZIDOVUDINE
P 6154X Capsule 250mg 240 0.60 GM 182 —

J05 - ANTIVIRALS FOR SYSTEMIC USE

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
ANTIVIRALS FOR SYSTEMIC USE
DIRECT ACTING ANTIVIRALS
NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
J05AG03 EFAVIRENZ
P 6356M Tablet 600mg 60 0.60 GM 201 85,837
J05AG01 NEVIRAPINE
P 6215D Tablet 200mg 120 0.40 GM 5,220 1,833,334
NEURAMINIDASE INHIBITORS
J05AH02 OSELTAMIVIR
A 17034 Capsule 75mg 10 — — 28,267 —
A 20830 Capsule 30mg 10 0.15 GM 144 —
J05AH01 ZANAMIVIR
A 16327 Rotadisk 5mg 20 20.00 MG 1,034 —
ANTIVIRALS FOR TREATMENT OF HIV INFECTION, COMBINATIONS
J05AR LOPINAVIR with RITONAVIR
P 6495W Tablet 200mg-50mg 240 — — 4,445 3,748,601
J05AR03 TENOFOVIR with EMTRICITABINE
P 6468K Tablet containing tenofovir disoproxil fumarate 300mg with emtricitabine 200mg 60 — — 362 326,170
J05AR06 TENOFOVIR with EMTRICITABINE and EFAVIRENZ
P 9650X Tablet containing tenofovir disoproxil fumarate 300mg with emtricitabine 200mg and efavirenz 600mg 60 — — 145 230,697
J05AR01 ZIDOVUDINE and LAMIVUDINE
P 6234D Tablet 150mg-300mg 120 — — 1,570 1,036,261
J05AR04 ZIDOVUDINE with LAMIVUDINE with ABACAVIR
P 6327B Tablet 300mg-150mg-300mg (as sulfate) 120 — — 574 —

J07 - VACCINES

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
VACCINES
BACTERIAL VACCINES
CHOLERA VACCINES
J07AE01 CHOLERA
A 20362 Oral granules inactivated choleme 2 — — 21,661 —
J07AE02 CHOLERA, LIVE ATTENUATED
A 18382 Oral granules Cholera, inactivated 14 — — 19,345 —
MENINGOCOCCAL VACCINES
J07AH04 MENINGOCOCCAL
A 14507 Vial 0.5mL 1 — — 6,417 —
A 15130 Vial 0.5mL 1 — — 223 —
J07AH07 MENINGOCOCCAL C
A 17391 Vial 0.5mL 1 — — 271 —
A 17637 Syringe 10ug per 0.5mL conjugated 1 — — 113 —
A 20145 Injection 10mg per 0.5mL prefilled syringe 1 — — 172 —
PERTUSSIS VACCINES
J07AJ52 DIPHTERIA with TETANUS with PERTUSSIS PURIFIED ANTIGEN
A 17092 Injection 0.5mL 1 — — 59,691 —
J07AJ51 DIPHTHERIA, TETANUS and PERTUSSIS VACCINE, ADSORBED
A 19778 Injection 0.5mL — — 12,111 —
PNEUMOCOCCAL VACCINES
J07AL01 PNEUMOCOCCAL
P 1903E Injection 0.5mL (23 valent) — — 19,582 900,570
TETANUS VACCINES
J07AM51 TETANUS TOXOID, COMBINATIONS with DIPTHERIA
P 3463G Injection 0.5mL in pre-filled syringe — — 26,803 5,767,020
P 8783G Injection 0.5mL in pre-filled syringe — — 7,936 488,370
TYPHOID,VACCINES
J07AP01 SALMONELLA-TYPHI
A 19176 Oral live attenuated capsule Typhoid — — 5,317 —
J07AP03 TYPHOID PURIFIED POLYSACCHARIDE ANTIGEN
A 14718 Syringe 0.5mL — — 83,514 —
A 16719 Injection 25ug — — 24,528 —
VIRAL VACCINES
ENCEPHALITIS VACCINES
J07BA02 JAPANESE ENCEPHALITIS VACCINE
A 20716 Pre-filled syringe 0.5mL — — 221 —
INFLUENZA VACCINES
J07BB02 INFLUENZA VACCINE
A 20834 Injection 0.1mL — — 25,207 —
A 21010 Injection (trivalent) 0.5mL — — 107,507 —
A 21011 Injection (trivalent) 0.25mL — — 367 —
A 21012 Injection (trivalent) 0.5mL — — 88,773 —
A 21013 Injection (trivalent) 0.5mL — — 21,973 —
P 2852D Injection (trivalent) 0.5mL — — 26,939 26,245

J07 - VACCINES

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
GENERAL ANTIINFECTIVES FOR SYSTEMIC USE
VACCINES
VIRAL VACCINES
HEPATITIS VACCINES
J07BC02 HEPATITIS A
A 15677 Syringe 720u/0.5mL — — 29,264 —
A 15687 Syringe 144u 1 — — 59,347 —
A 15770 Syringe 25u 1 — — 421 —
A 17617 Vial 0.5mL 1 — — 181 —
J07BC20 HEPATITIS A\HEPATITIS B
A 15760 Syringe 1mL — — 92,279 —
A 15917 Syringe 0.5mL — — 1,623 —
A 17055 Syringe 0.5mL — — 980 —
J07BC01 HEPATITIS B
A 12913 Vial 1mL 1 — — 252 —
A 13026 Ampoule 20ug per mL 1 — — 53,822 —
A 13473 Ampoule 10ug per 0.5mL 1 — — 1,528 —
A 20760 Pre-filled syringe 20ug per mL 1 — — 19,168 —
A 20833 Pre-filled syringe 10ug per 0.5mL 1 — — 507 —
J07BC20 SALMONELLA and HEPATITIS A
A 17818 Prefilled syringe 25ug and 160 Elisa units — — 105,658 —
MEASLES VACCINES
J07BD52 MEASLES with MUMPS with RUBELLA
A 18509 Injection 0.5mL 1 — — 6,947 —
POLIOMYELITIS VACCINES
J07BF03 POLIOMYELITIS
A 16235 Injection 0.5mL — — 7,084 —
RABIES VACCINES
J07BG01 RABIES INACTIVATED
A 14107 Injection 1mL 1 — — 1,819 —
A 19166 Injection 2.5ug 1 — — 2,232 —
RUBELLA VACCINES
J07BJ01 RUBELLA
A 11227 Injection 0.5mL — — 146 —
VARICELLA VACCINES
J07BK01 VARICELLA LIVE ATTENUATED
A 16723 Vaccine 0.5mL — — 6,701 —
A 17821 Vaccine 0.5mL — — 147 —
PAPILLOMAVIRUS VACCINES
J07BM02 VACCINE PAPILLOMAVIRUS (HUMAN TYPES 16 and 18)
A 20142 Injection 0.5mL prefilled syringe 1 — — 1,952 —
J07BM01 VACCINE PAPILLOMAVIRUS (HUMAN TYPES 6, 11, 16 and 18)
A 10756 Injection 0.5mL prefilled syringe 1 — — 5,508 —
BACTERIAL AND VIRAL VACCINES, COMBINED
BACTERIAL AND VIRAL VACCINES, COMBINED
J07CA02 DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS

D09 - MEDICATED DRESSINGS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
DERMATOLOGICALS
MEDICATED DRESSINGS
MEDICATED DRESSINGS
OINTMENT DRESSINGS WITH ANTIINFECTIVES
D09AA CADEXOMER IODINE
P 4932N Tube 10g 4 — — 836 86,440
P 4933P Tube 20g 2 — — 317 32,291
ZINC BANDAGES
D09AB01 BANDAGE ZINC PASTE
P 4750B Bandage 7.5cm x 6m — — 557 46,646
SOFT PARAFFIN DRESSINGS
D09AX SOFT PARAFFIN DRESSING
P 4759L Sterile sachets 10cm x 10cm 10 — — 1,485 35,260
P 4845B Sterile sachets 10cm x 10cm 10 — — 1,157 30,794
Last updated
1 January 2010